- Home
- CIGL vs INCR Comparison
CIGL vs INCR Comparison
Compare CIGL & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CIGL | INCR |
|---|---|---|
| Founded | 1997 | 1994 |
| Country | Singapore | Israel |
| Employees | 134 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.8M | 50.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CIGL | INCR |
|---|---|---|
| Price | $1.65 | $0.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 45.8K | 44.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $69.54 |
| Revenue Next Year | N/A | $41.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.40 | $0.68 |
| 52 Week High | $25.00 | $1.77 |
Technical Indicators
Market Signals| Indicator | CIGL | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 43.17 | 41.97 |
| Support Level | $1.52 | $0.76 |
| Resistance Level | $2.20 | $0.88 |
| Average True Range (ATR) | 0.13 | 0.04 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 16.67 | 31.68 |
Price Performance
Historical ComparisonAbout CIGL Concorde International Group Ltd Class A Ordinary Shares
Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.